Nanologica AB (NICA) — Cash Flow-to-Debt Ratio
Nanologica AB (NICA) has a Cash Flow-to-Debt Ratio of -0.14x as of December 2025, meaning its operating cash flow of Skr-9.45 Million could theoretically repay 0% of its total liabilities (Skr65.47 Million) in one year. See how much free cash does Nanologica AB generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanologica AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Nanologica AB across 11 annual periods. Also explore how fast is Nanologica AB growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nanologica AB (2015–2025)
Year-by-year debt coverage analysis for Nanologica AB. For market capitalisation and broader financial context, see NICA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | Skr-39.88 Million | Skr65.47 Million | ▲ +47.9% |
| 2024 | -1.17x | Skr-80.73 Million | Skr68.99 Million | ▼ -159.0% |
| 2023 | -0.45x | Skr-35.85 Million | Skr79.33 Million | ▲ +18.7% |
| 2022 | -0.56x | Skr-45.22 Million | Skr81.36 Million | ▲ +44.1% |
| 2021 | -1.00x | Skr-46.49 Million | Skr46.72 Million | ▼ -22.6% |
| 2020 | -0.81x | Skr-43.34 Million | Skr53.38 Million | ▼ -168.9% |
| 2019 | -0.30x | Skr-11.52 Million | Skr38.16 Million | ▲ +72.6% |
| 2018 | -1.10x | Skr-11.71 Million | Skr10.62 Million | ▼ -13.9% |
| 2017 | -0.97x | Skr-23.19 Million | Skr23.98 Million | ▲ +59.0% |
| 2016 | -2.36x | Skr-23.19 Million | Skr9.84 Million | ▼ -45.8% |
| 2015 | -1.62x | Skr-13.95 Million | Skr8.63 Million | — |